Fairmount Funds Management Llc Portfolio Stock Holdings

Fairmount Funds Management Llc disclosed 12 stock positions valued at approximately $1.4 billion in its latest SEC 13F filing. The largest holdings include DIANTHUS THERAPEUTICS INC, COGENT BIOSCIENCES INC, and SPYRE THERAPEUTICS INC. The filing reflects positions held as of March 31, 2026 and was filed on May 15, 2026.

Report Period
March 31, 2026
No. of Stocks
12
Portfolio Value
$1.4B
Holdings by Sector
Fairmount Funds Management Llc Portfolio Holdings in Q1 2026

7 holdings in the latest reporting period.

Page 1 of 1
CompanySymbolSectorPortfolio %SharesChange (Shares)Change %Value
DIANTHUS THERAPEUTICS INCDNTHHealthcare15.38%2,537,191+400,000+18.72%$212,921,069
COGENT BIOSCIENCES INCCOGTHealthcare15.30%5,503,418-3,500,000-38.87%$211,826,559
SPYRE THERAPEUTICS INCSYREHealthcare14.64%4,018,101--$202,673,014
VIRIDIAN THERAPEUTICS INCVRDNHealthcare5.53%3,914,458--$76,566,798
ENLIVEN THERAPEUTICS INCELVNHealthcare5.25%1,855,644-1,855,800-50.00%$72,741,245
APOGEE THERAPEUTICS INCAPGEHealthcare1.82%298,647-1,750,000-85.42%$25,137,118
INHIBIKASE THERAPEUTICS INCIKTHealthcare1.05%8,625,000--$14,490,000